# Braskem SA ADR (BAK) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Chemicals. Price $1.89, market value $753 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Braskem SA ADR reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.1×**. Each dollar of revenue is priced at 0.1×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **EV / EBITDA: 5.5×**. Enterprise value is 5.5× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: -231.6%**. Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 8.9%**. Braskem SA ADR keeps 8.9% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 4.4%**. 4.4% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: -14.0%**. The company reported a net loss over the last twelve months.
- **Return on equity: 61.2%**. A 61.2% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 3.6%**. Return on all capital, debt included, is 3.6%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -6.8%**. Each dollar of assets produces -6.8% of profit.

## Growth
- **Revenue growth (1 yr): -8.6%** (3-yr -9.8%/yr, 5-yr 3.9%/yr). Revenue fell 8.6% over the last year, against 3.9% a year compounded over five years: growth is slowing.

## Financial health
- **Net debt / EBITDA: 5.1×**. It would take 5.1 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Interest coverage: 0.6×**. Operating profit covers interest only 0.6×: fragile.
- **Current ratio: 0.76** (quick 0.50). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 0.38**. A Z-score of 0.38 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Braskem SA ADR does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (4 analysts). 4 analysts cover Braskem SA ADR; the consensus is hold, with an average price target of $3.25 (+72% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -44.6%** (YTD -35.9%, 3-mo -45.7%). The shares are down 44.6% over twelve months including dividends.
- **From 52-week high: -65.0%** (35.0% above the low). Trading 65% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 1.68** (volatility 81%). Beta of 1.68 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BAK · Page: https://foliofundamentals.com/stocks/bak

Not investment advice.